Anti-diabetic and Anti-hyperlipidemic Effects and Safety of Salacia reticulata and Related Species

Phytotherapy Research

Volumn 29, Issue 7, 2015, Pages 986-995

  Stohs, Sidney J ^a   Ray, Sidhartha ^b  

^a AdvoCare International   (United States)

^b MANCHESTER UNIVERSITY   (United States)

Author keywords

anti hyperlipidemic; antidiabetic; antioxidant; hepatoprotectant; Salacia reticulata

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; EPIAFZELECHIN; EPICATECHIN; EPIGALLOCATECHIN; KOTALAGENIN 16 ACETATE; KOTALANOL; MANGIFERIN; PONKORINOL; PROANTHOCYANIDIN; SALACIA CHINENSIS EXTRACT; SALACIA OBLONGA EXTRACT; SALACIA RETICULATA EXTRACT; SALACINOL; SALAPRINOL; UNCLASSIFIED DRUG; ANTIOXIDANT; KOTALAGENIN 16-ACETATE; MONOSACCHARIDE; PLANT EXTRACT; SUGAR ALCOHOL; SULFATE; TRITERPENE; XANTHONE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; CARBOHYDRATE METABOLISM; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; HUMAN; LIPID METABOLISM; LIVER PROTECTION; NONHUMAN; PLANT LEAF; PLANT ROOT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALACIA; SALACIA RETICULATA; TOXICITY TESTING; ANIMAL; CHEMISTRY; DIABETES MELLITUS; DRUG EFFECTS; MOUSE; RAT;

ANIMALIA; MUS; RATTUS; SALACIA CHINENSIS; SALACIA OBLONGA; SALACIA RETICULATA;

ANIMALS; ANTIOXIDANTS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; HUMANS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MICE; MONOSACCHARIDES; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PROANTHOCYANIDINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; SALACIA; SUGAR ALCOHOLS; SULFATES; TRITERPENES; XANTHONES;

EID: 84936871713     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5382     Document Type: Review

References (67)

1. Akaki J, Morikawa T, Miyaka S, et al,. 2014. Evaluation of Salacia species as anti-diabetic natural resources based on quantitative analysis of eight sulphonium constituents: a new class of α-glucosidase inhibitors. Phytochem Anal 25: 544-550.
2. Akase T, Shimada T, Harasawa Y, et al,. 2011. Preventive effects of Salacia reticulata on obesity and metabolic disorders in TSOD mice. Evid Based Compl Alt Med. DOI: 10.1093/ecam/nep052.
3. Arunakumara KKIU, Subasinghe S,. 2010. Salacia reticulata WIGHT: A review of botany, phytochemistry and pharmacology. Trop Agr Res Extens 13: 41-47.
4. Bhat BM, Raghuveer CV, D'Souza V, Manjrekaar PA,. 2012. Antidiabetic and hypolipidemic effect of S. oblonga in streptozotocin-induced diabetic rats. J Clin Diagn Res 6: 1685-1687.
5. Chandrashekar CN, Madhyastha S, Benjamin S, et al,. 2009. Free radical scavenging activities and anti-diabetic properties of various extracts of Salacia reticulata. J Physiol Sci 21: 48-57.
6. Collene AL, Hertzler SR, Williams JA, et al,. 2005. Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults. Nutrition 21: 848-854.
7. Flammang AM, Erexson GL, Mirwald JM, et al,. 2007. Toxicological and cytogenetic assessment of a Salacia oblonga extract in a rat subchronic study. Food Chem Toxicol 45: 1954-1962.
8. Gao XH, Xie N, Feng F,. 2008. Studies on chemical constituents of Salacia prinoides. Zhong Yao Cai 31: 1348-1351.
9. Giron MD, Sevillano N, Salto R, et al,. 2009. Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin. Clin Nutr 28: 565-574.
10. He L, Rong X, Jiang J, et al,. 2011. The ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II AT1 signalling. Evid Based Compl Alt Med. DOI: 10.1093/ecam/nepo95.
11. Heathcock PM, Hertzler SR, Williams JA, et al,. 2005. Effects of a medical food containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. J Amer Diet Assoc 105: 65-71.
12. Huang TH, Yang Q, Harada M, et al,. 2006. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol 210: 78-85.
13. Huang TH, He L, Qin Q, et al,. 2008. Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes Obes Metab 10: 574-585.
14. Im R, Mano HJ, Nakatani S, et al,. 2008. Safety evaluation of the aqueous extract Kothala himbutu (Salacia reticulata) stem in the hepatic gene expression profile of normal mice using DNA microarrays. Biosci Biotechnol Biochem 72: 3075-3083.
15. Im R, Mano H, Matsuura T, et al,. 2009. Mechanisms of blood glucose-lowering effect of aqueous extract from stems of Kotala himbutu (Salacia reticulata) in the mouse. J Ethnopharmacol 121: 234-240.
16. Ismail TS, Gopalakrishnan S, Begum VH, et al,. 1997. Anti-inflammatory activity of Salacia oblonga Wall. and Azima tetracantha Lam. J Ethnopharmacol 56: 145-152.
17. Jayawardena MH, de Alwis NM, Hettigoda V, et al,. 2005. A double blind randomized placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes. J Ethnopharmacol 97: 215-218.
18. Kajimoto O, Kawamuri S, Shimoda H, et al,. 2000. Effects of diet containing Salacia reticulata on mild type 2 diabetes in humans-a placebo controlled cross over trail. J Jap Soc Nutr Food Sci 53: 199-205.
19. Kannan M, Saravanan S, Sagayam S, et al,. 2011. Toxicological evaluation of ethanolic extract of Salacia chinensis roots in Wistar albino rats. Int J Univ Pharm Life Sci 1: 145-153.
20. Karunanayake EH, Welihinda J, Sirimanne SR, et al,. 1984. Oral hypoglycemic actrivity of some medicinal plants of Sri Lanka. J Ethnopharmacol 11: 223-231.
21. Kataoka K,. 2006. The hypoglycemic potential and safety profile of Salacia reticulate Wight extract powder in healthy and diabetic subjects. New Diet Ther 20: 47-53.
22. Kishino E, Ito T, Fujita K, et al,. 2006. A mixture of Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity. J Nutr 136: 433-439.
23. Kishino E, Ito T, Fujita K, et al,. 2009. A mixture of Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces body weight gain, visceral fat accumulation, and total cholesterol and insulin increases in male Wistar fatty rats. Nutr Res 29: 55-63.
24. Koga K, Hisamura M, Kanetaka T, et al,. 2013. Proanthocyanidin oligomers isolated from Salacia reticulate leaves potently inhibit pancreatic lipase activity. J Food Sci 78: 105-111.
25. Koteshwar P, Raveeendra KR, Allan JJ, et al,. 2013. Effect of NR-Salacia on post-prandial hyperglyceria: a randomized double-blind, placebo-controlled, cross-over study in healthy vounteers. Phamracogn Mag 9: 344-349.
26. Kurian GA, Manjushi V, Nair SS, et al,. 2014. Short-term effect of G-400, a polyherbal formulation in the management of hyperglycemia and hyperlipidemia conditions in patients with type 2 diabetes. Nutrition 30: 1156-1164.
27. Krishnakumar K, Augusti KT, Vijayammal PL,. 1999. Hypoglycaemic and anti-oxidant activity of Salacia oblonga Wall. extract in streptozotocin-induced rats. Indian J. Physiol. Pharmacol 43: 510-514.
28. Li Y, Peng G, Wen S, et al,. 2004. Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci 75: 1735-1746.
29. Li Y, Huang TH, Yamahara J,. 2008. Salacia root, a unique ayurvedic medicine, meets multiple targets in diabetes and obesity. Life Sci 82: 1045-1049.
30. Matsuda H, Murakami T, Yashiro K, et al,. 1999. Anti-diabetic principles of natural medicines. IV. Aldose reductase and α-glucosidase inhibitors from the roots of Salacia oblonga WALL. (Celastraceae): structure of a new friedalane-type triterpene, kotalagenin 16-acetate. Chem Pharm Bull 47: 1725-1729.
31. Mohan S, Eskandari R, Pinto BM,. 2014. Naturally occurring sulfonium ion glucosidase inhibitors and their derivatives: a promising class of potential antri-diabetic agents. Acc Chem Res 47: 211-225.
32. Morikawa T, Kishi A, Pongpiriyadacha Y, Matsuda H, Yoshikawa M,. 2003. Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpenes and aldose reductase inhibitors form Salacia reticulata. J Nat Prod 55: 1191-1196.
33. Morikawa T, Akaki J, Ninomiya K, et al., 2015. Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis. Nutrients 7: 1480-1493.
34. Muraoka O, Morikawa T, Miyake S, et al,. 2010. Quantitative determination of potent alpha-glucosidase inhibitors, salacinol and kotalanol, in Salacia species using liquid chromatograph-mass spectrometry. J Pharm Biomed Anal 52: 770-773.
35. Muruganandan S, Gupta S, Kataria M, et al,. 2002. Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 176: 165-173.
36. Muruganandan S, Srinivasan K, Gupta S, et al,. 2005a. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97: 497-501.
37. Muruganandan S, Lal J, Gupta PK,. 2005b. Immunotherapeutic effects of mangiferin mediated by inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology 215: 57-68.
38. Nakamura S, Zhang Y, Matsuda H, et al,. 2011. Chemical structures and hepatoprotective effects of constituents from the leaves of Salacia chinensis. Chem Pharm Bull 59: 1020-1028.
39. Nataka K, Taniguchi Y, Yoshioka N, et al,. 2011. A mixture of Salacia oblonga extract and IP-PA1 reduces fasting plasma glucose (FPG) and low-density lipoprotein (LDL) cholesterol levels. Nutr Res Pract 5: 435-442.
40. Oe H, Ozaki S,. 2008. Hypoglycemic effect of 13-membered ring thiocyclitol, a novel alpha-glucosidase inhibitor from Kothala-himbutu (Salacia reticulata). Biosci Biothechnol Biochem 72: 1962-1964.
41. Radha R, Amrithaveni M,. 2009. Role of medicinal plant Salacia reticulata in the management of type II diabetic subjects. Anc Life Sci 29: 14-16.
42. Rajashree R, Parineetha P, Bjhat P, et al,. 2011. Effects of a mixture of Salacia reticulata W. and Catharanthus roseus L. extracts in streptozotocin-induced juvenile diabetic rats. J Physiol Biomed Sci 24: 5-8.
43. Rong X, Kim MS, Su N, et al,. 2008. An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage for 28 days induces gender-dependent hepatic hypertrophy in rats. Food Chem Toxicol 46: 2165-2172.
44. Ruvin Kumara NKVM, Pathirana RN, Pathirana C,. 2005. Hyperglycemic activity of the root and stem of Salacia reticulata var. β-diandra in alloxan diabetic rats. Pharmaceut Bull 43: 219-225.
45. Sekiguchi Y, Mano H, Nakatani S, Shimizu J, Kobata K, Wada M,. 2012. Anti-proliferative effects of Salacia reticulata leaves hot-water extract on interleukin-1β-activated cells derived from the synovium of rheumatoid arthritis model mice. BMC Res Notes 5: 198. DOI: 10.1186/1756-0500-5-198.
46. Sellamuthu PS, Arulselvan P, Muniappan BP, Fakurazi S, Kandasamy M,. 2013. Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin-induced diabetic rats. J Med Food 16: 719-727.
47. Sellamuthu PS, Arulselvan P, Fakurazi S, Kandasamy M,. 2014. Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes. Pak J Pharm Sci 27: 161-167.
48. Shimada T, Nagai E, Harasawa Y, et al,. 2010. Metabolic disease prevention and suppression of fat accumulation by Salacia reticulata. J Nat Med 64: 266-274.
49. Shimada T, Nagai E, Harasawa Y, et al,. 2011. Salacia reticulata inhibits differentiation of 3 T3-L1 adipocytes. J Ethnopharmacol 136: 67-74.
50. Shimada T, Nakayama Y, Harasawa Y, et al,. 2014. Salacia reticulata has therapeutic effects on obesity. J Nat Med 68: 668-676.
51. Shimoda H, Kawamori S, Kawahara Y,. 1998. Effects of an aqueous extract of Salacia reticulata, a useful plant in Sri Lanka, on postprandial hyperglycemia in rats and humans. Nippon Eiyo Shokuryo Gakkaishi 151: 279-287.
52. Shimoda H, Fujimura T, Makino K, et al,. 1999. Safety profile of extractive from trunk of Salacia reticulata (Colastraceae). J Food Hyg Soc Jap 40: 198-205.
53. Shimoda H, Asano I, Yamada Y,. 2001. Antigenicity and phototoxicity of water-soluble extract from Salacia reticulata (Celastraceae). Shokuhin Eiseigaku Zasshi 42: 144-147.
54. Shivaprasad HN, Bhanumathy M, Sushma T, et al,. 2013. Salacia reticulata improves serum lipid profiles and glycemic control in patients with pre-diabetes and mild to moderate hyperlipidemia: a double-blind, placebo-controlled, randomized trial. J Med Food 16: 564-568.
55. Sim L, Jayakanthan K, Mohan S, et al,. 2010. New glucosidase inhibitors for an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Biochemistry 49: 443-451.
56. Singh RG, Rathore SS, Wani IA, et al,. 2015. Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: a prospective study. Saudi J Kidney Dis Transpl 26: 61-66.
57. Suwannalert P, Kariya R, Suzu I, Okada S,. 2014. The effects of Salacia reticulata on anti-cellular oxidants and melanogenesis inhibition in alpha-MSHstimulated and UV irradiated B16 melanoma cells. Nat Prod Commun 9: 551-554.
58. Tanimura C, Terada I, Hiramatu K, et al,. 2005. Effect of a mixture of aqueous extract from Salacia reticulata (Kotala himbutu) and cyclodextrin on the serum glucose and the insulin levels in sucrose tolerance test and on serum glucose level changes and gastrointestinal disorder by massive ingestion. Yonago Igaku ZAsshi 56: 85-93.
59. Venkateswarlu V, Kokate CK, Rambhau D, Veeresham C,. 1993. Antidiabetic activity of roots of Salacia macrosperma. Planta Med 59: 391-393.
60. Williams JA, Choe YS, Noss MJ, et al,. 2007. Extract of Salacia oblonga lowers acute glycemia in patients with type 2 diabetes. Amer J Clin Nutr 86: 124-130.
61. Wolf BW, Weisbrode SE,. 2003. Safety evaluation of an extract form Salacia oblonga. Food Chem Toxicol 41: 867-874.
62. Xie W, Tanabe G, Akaki J, et al,. 2011. Isolation, structure identification and SAR studies on the thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Bioorg Med Chem 19: 2015-2022.
63. Yokotani K, Chiba T, Sato Y, et al,. 2013. Effect of three herbal extracts on cytochrome P450 and possibility of interactions with drugs. Shakuhin Eiseiguku Zasshi 54: 56-64.
64. Yoshikawa M, Nishida N, Shimoda H, et al,. 2001. Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities. Yakugaku Zasshi 121: 371-378.
65. Yoshikawa M, Shimoda H, Nisida N, et al,. 2002a. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild anti-obesity effects in rats. J Nutr 132: 1819-1824.
66. Yoshikawa M, Ninomiya K, Shimoda H, Nishida N, Matsuda H,. 2002b. Hepatoprotective and antioxidant properties of Salacia reticulata: preventive effects of phenolic constituents on CCl4-induced liver injury in mice. Biol Pharm Bull 25: 72-76.
67. Yoshino K, Miyauchi Y, Kanetaka T, et al,. 2009. Anti-diabetic activity of a leaf extract prepared from Salacia reticulata in mice. Biosci Biotechnol Biochem 73: 1096-1104.